Skip Ribbon Commands
Skip to main content

Peritoneal based Malignancies

Peritoneal based Malignancies - How to prevent?

Peritoneal based Malignancies - Causes and Risk Factors

Peritoneal based Malignancies - Treatments

​Treatment includes cytoreductive surgery (CRS), peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). This involves removal of the peritoneum, any involved organ and the introduction of heated chemotherapy drug directly into the abdominal cavity. This surgical procedure aims to remove all visible tumours completely with the intention of curing. The chemotherapy treats any microscopic tumour that may be present.

Not all patients with peritoneal disease may be suitable candidates for surgery. All patients that are being considered for the surgery are discussed at our multidisciplinary tumour boards. Surgical oncologists, medical oncologists, radiation oncologists, specialized radiologists and pathologists will review the cases, any pathology and imaging. The most appropriate treatment plan for each patient is decided as a consensus.

Patients who are suitable for surgery

  • Patient with tumours that arise from the peritoneum.
  • Patients who have primary tumours in the ovary, colon and appendix who have no evidence of distant metastasis.
  • Patients who are medically fit for surgery and anaesthesia.
The information provided is not intended as medical advice. Terms of use. Information provided by SingHealth